학술논문
Combination treatment of usnic acid and sorafenib on hepatocellular carcinoma
OP-21-009
OP-21-009
Document Type
Disease/Disorder overview
Author
Source
Erciyes Medical Journal. June 2019, Vol. 41 Issue S1, p16, 1 p.
Subject
Language
English
ISSN
2149-2247
Abstract
Sorafenib (SOR) is the only drug approved for the treatment of hepatocellular carcinoma (HCC). However, SOR can cause significant toxicity in patients and thus, it is necessary to develop new [...]